UV Clinical A/S: Financial statements 2025
CVR: 38401572
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
UV Clinical A/S (CVR 38401572) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 1,274,253 and a net result of DKK -1,282,165 compared with DKK -1,895,100 the year before. That is an increase of 224.7% compared with the year before. Equity in the 2025 report amounted to DKK 22,796,335. The solvency ratio was 67.5%. The company had 3 employees in the financial year.
- Gross Profit
- DKK 1,274,253
- Profit/Loss
- DKK -1,282,165
- Equity
- DKK 22,796,335
- Total Assets
- DKK 33,766,453
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 1.3M | -1.3M | 22.8M | 3 |
| 2024 | - | 392K | -1.9M | 20.1M | 2 |
| 2023 | - | 2.2M | -417K | 8.2M | 2 |
| 2022 | - | 151K | -269K | 1.7M | 1 |
| 2021 | - | 33K | 2.2M | 124K | 1 |
Official annual report
How creditworthy is UV Clinical A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
UV Clinical A/S has published its annual report for 2024. Gross profit came to DKK 392,414, and the net result was DKK -1,895,100.
As of February 21, 2025, Canajo Invest ApS is registered as an owner of UV Clinical A/S with an ownership share of 25%.
About UV Clinical A/S
UV Clinical A/S is a Danish company of the type Aktieselskab based in Hellerup, founded in 2017. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The company was previously named UV Clinical ApS. The management consists of Rolf Henrik Sprunk-Jansen. The board consists of Helge Holm-Larsen (chair), Emilio de la Guardia Gascuñana and Rolf Henrik Sprunk-Jansen. The company is owned by Ulstrup Invest ApS, Canajo Invest ApS and Holafa ApS. The company has 3 employees (2026). In 2025, the company reported a gross profit of DKK 1,274,253 and a net result of DKK -1,282,165 compared with DKK -1,895,100 the year before. Equity in the 2025 report amounted to DKK 22,796,335.
